Clinical Trials, Genetic Engineering and Packaging

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Trials

Genetic Engineering

Packaging

Overcoming inefficiencies to improve access to cell and gene therapy

Drug Discovery World

MARCH 13, 2023

Between the 24 therapies already approved by the FDA 1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. The cell and gene therapy (CGT) landscape has grown significantly in the past year. Lauren Collison , PhD, Senior VP, Operations & Site Head, KBI Biopharma, reflects.

Gene Therapy

Gene Therapy Gene Manufacturing Development

Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease in PREVENT-19 Phase 3 trial

The Pharma Data

JUNE 25, 2021

It is also being tested in two ongoing Phase 2 studies that began in August 2020: A Phase 2b trial in South Africa that demonstrated 55% efficacy overall in HIV-negative participants and 48.6% It is packaged in a ready-to-use liquid formulation in 10-dose vials. efficacy against the B.1.351 and Australia. About Matrix-M Adjuvant.

Vaccination

Vaccination Vaccine Trials Immune Response

Clinical Research Informer

Overcoming inefficiencies to improve access to cell and gene therapy

Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease in PREVENT-19 Phase 3 trial

Stay Connected